1. Market Research
  2. > Pathology Industry

Arthritis Industry, October 2016 Market Reports from Top Publishers

You might be interested in: Therapy, Autoimmune Disease, Infectious Disease, Diagnostics, Pharmaceutical, Biosimilar, Musculoskeletal Disorder, Analgesic, Injectable Delivery, Clinical Trial, Prosthesis, Anti Rheumatic, Orthobiologics, Orthopedic Prosthesis, Cloud Computing, Eye Disease, Stem Cell, Monoclonal Antibody, Protein, Sports Medicine.


 
1-10 of about 200 reports for Arthritis

Purchase Reports From Reputable Market Research Publishers

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

  • $ 5 650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based ...

Global Rheumatoid Arthritis Market DataPack (2016-2020)

Global Rheumatoid Arthritis Market DataPack (2016-2020)

  • $ 450
  • Industry report
  • September 2016
  • by Koncept Analytics

The Industry DataPack provides a unique mix of market information, analysis and estimates based on quantitative and qualitative research. The market figures and industry dynamics are given in order to ...

Global Rheumatoid Arthritis Partnering 2010 to 2016

Global Rheumatoid Arthritis Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Global Arthritis Partnering 2010 to 2016

Global Arthritis Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Psoriatic Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Psoriatic Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Psoriatic Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Osteoarthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Osteoarthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Osteoarthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Juvenile Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Juvenile Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Juvenile Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

About 10 000 reports for Arthritis

Download Unlimited Documents from Trusted Public Sources

Arthritis Statistics and Autoimmune Disease Statistics in Australia

  • October 2014
    140 pages
  • Arthritis  

    Autoimmune Dise...  

  • Australia  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.